Rangeley Capital’s Surmodics SRDX Stock Holding History

Rangeley Capital’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$299K	–	157
2025 Q3	$299K	Buy	+10,000	New	+$334K	0.26%	72

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rangeley Capital's SRDX Position: Q4 2025 in Review

Rangeley Capital sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 10,000 shares — an estimated $299K sold.

Rangeley Capital first reported a position in SRDX in Q3 2025 and held it in 1 quarter. The position peaked at $299K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Rangeley Capital reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Rangeley Capital sold 10,000 Surmodics shares in Q4 2025, an estimated $299K.
Rangeley Capital first reported a position in Surmodics in Q3 2025 and held it in 1 quarter.
Rangeley Capital's Surmodics position peaked at $299K in Q3 2025.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.